<生产厂家价格>

邻碘溴苄

邻碘溴苄名称

[ CAS 号 ]:
40400-13-3

[ 中文名 ]:
2-碘苯甲基溴

[ 英文名 ]:
α-Bromo-2-iodotoluene

[中文别名 ]:

[英文别名 ]:

o-Iodobenzyl bromide
α-Bromo-2-iodotoluene
2-Iodobenzyl bromide
1-(Bromomethyl)-2-iodobenzene
IR B1E
MFCD00236046
1-(Bromomethyl)iodobenzene
Benzene, 1-(bromomethyl)-2-iodo-
2-Iodo benzylbromide

邻碘溴苄物理化学性质

[ 密度 ]:
2.1±0.1 g/cm3

[ 沸点 ]:
278.8±15.0 °C at 760 mmHg

[ 熔点 ]:
54-60 °C(lit.)

[ 分子式 ]:
C₇H₆BrI

[ 分子量 ]:
296.931

[ 闪点 ]:
122.4±20.4 °C

[ 精确质量 ]:
295.869751

[ LogP ]:
3.95

[ 蒸汽压 ]:
0.0±0.6 mmHg at 25°C

[ 折射率 ]:
1.656

[ 储存条件 ]:
Refrigerator

邻碘溴苄MSDS

邻碘溴苄安全信息

[ 符号 ]:

GHS05, GHS07, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H302-H314-H334

[ 警示性声明 ]:
P261-P280-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
C:Corrosive;N:Dangerousfortheenvironment;

[ 风险声明 (欧洲) ]:
R22;R34;R43;R51/53

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S61-S45

[ 危险品运输编码 ]:
UN 3261 8/PG 2

[ WGK德国 ]:
2

[ 危险类别 ]:
8.0

[ 海关编码 ]:
2903999090

邻碘溴苄合成路线

邻碘溴苄上下游产品

邻碘溴苄上游产品

邻碘溴苄下游产品

邻碘溴苄海关

[ 海关编码 ]: 2903999090

[ 中文概述 ]:
2903999090 其他芳烃卤化衍生物. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:5.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%

邻碘溴苄文献

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

J. Comb. Chem. 11(1) , 34-43, (2009)

For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib...

Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.

J. Comb. Chem. 11 , 14-33, (2009)

Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa...

更多文献